Medical Marijuana, Inc. Investment AXIM(R) Biotechnologies, Inc. Secures Funding to Continue Pharma Clinical Trials Program in ...
Financing Enables Cannabinoid Innovator to Continue Phase I-II Trials Of Numerous Intellectual Property (IP) Protected Cannabinoid-Based Products for Multiple Indications SAN DIEGO, CA--(Marketwired - October 26, 2016) - Medical Marijuana, Inc. (OTC PINK: …